Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

About the Cover

November 1, 2022; Volume 63,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Gafita, Andrei

    1. Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
      Open Access
      Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
      Andrei Gafita, Isabel Rauscher, Manuel Weber, Boris Hadaschik, Hui Wang, Wesley R. Armstrong, Robert Tauber, Tristan R. Grogan, Johannes Czernin, Matthew B. Rettig, Ken Herrmann, Jeremie Calais, Wolfgang A. Weber, Matthias R. Benz, Wolfgang P. Fendler and Matthias Eiber
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1651-1658; DOI: https://doi.org/10.2967/jnumed.121.263072
  2. Galldiks, Norbert

    1. Cost Effectiveness of <sup>18</sup>F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
      You have access
      Cost Effectiveness of 18F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
      Jurij Rosen, Garry Ceccon, Elena K. Bauer, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Alexander Heinzel, Niklas Schäfer, Maximilian Ruge, Roland Goldbrunner, Gabriele Stoffels, Christoph Kabbasch, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1677-1682; DOI: https://doi.org/10.2967/jnumed.122.263790
  3. Ge, Jingjie

    1. Differential Diagnosis of Parkinsonism Based on Deep Metabolic Imaging Indices
      You have access
      Differential Diagnosis of Parkinsonism Based on Deep Metabolic Imaging Indices
      Ping Wu, Yu Zhao, Jianjun Wu, Matthias Brendel, Jiaying Lu, Jingjie Ge, Alexander Bernhardt, Ling Li, Ian Alberts, Sabrina Katzdobler, Igor Yakushev, Jimin Hong, Qian Xu, Yimin Sun, Fengtao Liu, Johannes Levin, Günter U. Höglinger, Claudio Bassetti, Yihui Guan, Wolfgang H. Oertel, Wolfgang Weber, Axel Rominger, Jian Wang, Chuantao Zuo and Kuangyu Shi
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1741-1747; DOI: https://doi.org/10.2967/jnumed.121.263029
  4. Geboers, Bart

    1. Robot-Assisted Prostate-Specific Membrane Antigen–Radioguided Surgery in Primary Diagnosed Prostate Cancer
      You have access
      Robot-Assisted Prostate-Specific Membrane Antigen–Radioguided Surgery in Primary Diagnosed Prostate Cancer
      William Gondoputro, Matthijs J. Scheltema, Alexander Blazevski, Paul Doan, James E. Thompson, Amer Amin, Bart Geboers, Shikha Agrawal, Amila Siriwardana, Pim J. Van Leeuwen, Matthias N. van Oosterom, Fijs W.B. Van Leeuwen, Louise Emmett and Phillip D. Stricker
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1659-1664; DOI: https://doi.org/10.2967/jnumed.121.263743
  5. Gephart, Melanie Hayden

    1. Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging
      Open Access
      Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging
      Quan Zhou, Nynke S. van den Berg, Wenying Kang, Jacqueline Pei, Naoki Nishio, Stan van Keulen, Myrthe A. Engelen, Yu-Jin Lee, Marisa Hom, Johana C.M. Vega Leonel, Zachary Hart, Hannes Vogel, Romain Cayrol, Brock A. Martin, Mark Roesner, Glenn Shields, Natalie Lui, Melanie Hayden Gephart, Roan C. Raymundo, Grace Yi, Monica Granucci, Gerald A. Grant, Gordon Li and Eben L. Rosenthal
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1693-1700; DOI: https://doi.org/10.2967/jnumed.121.263674
  6. Giesen, Danique

    1. <sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in Mice
      You have access
      89Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted 227Th-Conjugate Therapy in Mice
      Linda N. Broer, Daan G. Knapen, Frans V. Suurs, Ingrid Moen, Danique Giesen, Stijn J.H. Waaijer, Baard Indrevoll, Christine Ellingsen, Alexander Kristian, Alan S. Cuthbertson, Derk-Jan A. de Groot, Patricia E. Cole, Elisabeth G.E. de Vries, Urs B. Hagemann and Marjolijn N. Lub-de Hooge
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1715-1721; DOI: https://doi.org/10.2967/jnumed.121.263079
  7. Goldbrunner, Roland

    1. Cost Effectiveness of <sup>18</sup>F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
      You have access
      Cost Effectiveness of 18F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
      Jurij Rosen, Garry Ceccon, Elena K. Bauer, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Alexander Heinzel, Niklas Schäfer, Maximilian Ruge, Roland Goldbrunner, Gabriele Stoffels, Christoph Kabbasch, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1677-1682; DOI: https://doi.org/10.2967/jnumed.122.263790
  8. Gondoputro, William

    1. Robot-Assisted Prostate-Specific Membrane Antigen–Radioguided Surgery in Primary Diagnosed Prostate Cancer
      You have access
      Robot-Assisted Prostate-Specific Membrane Antigen–Radioguided Surgery in Primary Diagnosed Prostate Cancer
      William Gondoputro, Matthijs J. Scheltema, Alexander Blazevski, Paul Doan, James E. Thompson, Amer Amin, Bart Geboers, Shikha Agrawal, Amila Siriwardana, Pim J. Van Leeuwen, Matthias N. van Oosterom, Fijs W.B. Van Leeuwen, Louise Emmett and Phillip D. Stricker
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1659-1664; DOI: https://doi.org/10.2967/jnumed.121.263743
  9. Grant, Gerald A.

    1. Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging
      Open Access
      Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging
      Quan Zhou, Nynke S. van den Berg, Wenying Kang, Jacqueline Pei, Naoki Nishio, Stan van Keulen, Myrthe A. Engelen, Yu-Jin Lee, Marisa Hom, Johana C.M. Vega Leonel, Zachary Hart, Hannes Vogel, Romain Cayrol, Brock A. Martin, Mark Roesner, Glenn Shields, Natalie Lui, Melanie Hayden Gephart, Roan C. Raymundo, Grace Yi, Monica Granucci, Gerald A. Grant, Gordon Li and Eben L. Rosenthal
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1693-1700; DOI: https://doi.org/10.2967/jnumed.121.263674
  10. Granucci, Monica

    1. Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging
      Open Access
      Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging
      Quan Zhou, Nynke S. van den Berg, Wenying Kang, Jacqueline Pei, Naoki Nishio, Stan van Keulen, Myrthe A. Engelen, Yu-Jin Lee, Marisa Hom, Johana C.M. Vega Leonel, Zachary Hart, Hannes Vogel, Romain Cayrol, Brock A. Martin, Mark Roesner, Glenn Shields, Natalie Lui, Melanie Hayden Gephart, Roan C. Raymundo, Grace Yi, Monica Granucci, Gerald A. Grant, Gordon Li and Eben L. Rosenthal
      Journal of Nuclear Medicine November 1, 2022, 63 (11) 1693-1700; DOI: https://doi.org/10.2967/jnumed.121.263674
« Previous (Pages : 1 2 ... 2) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 63 (11)
Journal of Nuclear Medicine
Vol. 63, Issue 11
November 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET
  • Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire